In case anyone is interested, a new study was published yesterday showing mOS to be between 11-13 months for men treated with LuPSMA-617 who have 6 or more lesions:
mOS of 13-months (6-20 lesions)
mOS of 11 months (more than 20 lesions)
To put this in perspective, in the LuPIN trial 19 Men had < 20 metastases and 37 > 20 metastases for a mOS of 19.7 months.
A link to the article https://link.springer.com/article/10.1007/s00259-021-05383-3
Exquisite Timing, page-22
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.5¢ | $44.33K | 407.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19047 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 216870 | 2 |
View Market Depth
| Last trade - 13.14pm 16/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |